Discover Tema ETFs

Managed to pursue better outcomes

Our Exchange Traded Funds

  • Overview
  • Performance
  • Documents
Funds
Name
Fund Category
Price (NAV USD)
Inception Date
Total Net Assets
Net Expense Ratio*
# Holdings
Factsheet
Monopolies and Oligopolies ETF
TOLL
Strategic Equity
$29.91
05/10/23
$7.2M
0.75%
33
American Reshoring ETF
RSHO
Strategic Equity
$32.94
05/10/23
$12.2M
0.75%
33
Luxury ETF
LUX
Strategic Equity
$24.90
05/10/23
$8.2M
0.75%
30
Oncology ETF
CANC
Life Sciences
$27.72
08/14/23
$18.6M
0.75%
46
Global Royalties ETF
ROYA
Alternatives
$24.65
08/16/23
$5.2M
0.75%
27
Cardiovascular and Metabolic ETF
HRTS
Life Sciences
$32.58
11/20/23
$39.1M
0.75%
43
Neuroscience and Mental Health ETF
MNTL
Life Sciences
$25.53
01/22/24
$11.2M
0.75%
46

*Gross expense ratio for all above fund is 0.99%. Contractual expense cap for net expense ratio of 0.75% is in effect through 06/30/2024, except for HRTS where it is in effect till 06/30/2025.

As of 01/31/2024
Funds
Name
3 months
1Y (%)
3Y (%)
5Y (%)
Since Inception (%)
Inception Date
Monopolies and Oligopolies ETF
TOLL
21.39%
16.77%
05/10/2023
American Reshoring ETF
RSHO
19.22%
25.37%
05/10/2023
Luxury ETF
LUX
11.73%
-4.49%
05/10/2023
Oncology ETF
CANC
20.26%
4.52%
08/14/2023
Global Royalties ETF
ROYA
4.64%
0.45%
08/16/2023
Cardiovascular and Metabolic ETF
HRTS
17.56%
11/20/2023
Neuroscience and Mental Health ETF
MNTL
-1.18%
01/22/2024

Performance based on NAV, not market price.

Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Returns for periods of less than one year are not annualized.

For the most recent standardized and month end performance for each fund, please click on the respective fund names where these performance metrics can be found.

Funds
Name
Factsheet
Summary Prospectus
Investment Case
Statuary Prospectus
SAI
Infographic
Semi-Annual Report
Q3 2024 Portfolio Holdings
Monopolies and Oligopolies ETF
American Reshoring ETF
Global Royalties ETF
Cardiovascular and Metabolic ETF
Neuroscience and Mental Health ETF